IOL Chemicals & Pharmaceuticals Ratios

IOL Chemicals & Pharmaceuticals Ltd Ratios

The IOL Chemicals & Pharmaceuticals Ltd Ratios page provides a complete fundamental analysis of IOL Chemicals & Pharmaceuticals Ltd using key valuation, profitability, and financial strength metrics. Investors tracking IOL Chemicals & Pharmaceuticals Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

IOL Chemicals & Pharmaceuticals Ltd (NSE: IOLCP, BSE: 524164) is currently trading at ₹71.62, with a market capitalization of ₹21.3B. As a major player in the Process industries sector and Chemicals: specialty industry, IOL Chemicals & Pharmaceuticals Ltd remains a key stock for fundamental analysis using IOL Chemicals & Pharmaceuticals Ltd Ratios.

IOL Chemicals & Pharmaceuticals Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The IOL Chemicals & Pharmaceuticals Ltd P/E ratio currently stands at 17.77, making it one of the most tracked metrics in IOL Chemicals & Pharmaceuticals Ltd Ratios.

Historically, the IOL Chemicals & Pharmaceuticals Ltd P/E ratio has shown strong fluctuations:

• 2024: 17.77
• 2023: 78.93
• 2022: 11.94
• 2021: 12.39
• 2020: 7.22

The decline in IOL Chemicals & Pharmaceuticals Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The IOL Chemicals & Pharmaceuticals Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.06.

Historical P/B trend:

• 2024: 1.06
• 2023: 1.32
• 2022: 1.10
• 2021: 1.49

IOL Chemicals & Pharmaceuticals Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The IOL Chemicals & Pharmaceuticals Ltd P/S ratio currently stands at 0.87, an important part of IOL Chemicals & Pharmaceuticals Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 0.87
• 2023: 4.99
• 2022: 0.75
• 2021: 0.95

A stable or declining IOL Chemicals & Pharmaceuticals Ltd P/S ratio indicates cautious market sentiment.

IOL Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio (P/CF)

The IOL Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 10.20.

Historical IOL Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio:

• 2024: 10.20
• 2023: 36.95
• 2022: 13.44
• 2021: 20.06
• 2020: 8.30

The declining IOL Chemicals & Pharmaceuticals Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

IOL Chemicals & Pharmaceuticals Ltd Enterprise Value Ratios

Enterprise Value (EV)

The IOL Chemicals & Pharmaceuticals Ltd EV currently stands at ₹17.02B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 17.02B
• 2023: 104.98B
• 2022: 17.16B
• 2021: 19.79B

IOL Chemicals & Pharmaceuticals Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The IOL Chemicals & Pharmaceuticals Ltd EV/EBITDA ratio is currently 8.70, a key metric in IOL Chemicals & Pharmaceuticals Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 8.70
• 2023: 47.16
• 2022: 7.81
• 2021: 7.74

Stable IOL Chemicals & Pharmaceuticals Ltd EV/EBITDA indicates balanced valuation.

IOL Chemicals & Pharmaceuticals Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The IOL Chemicals & Pharmaceuticals Ltd D/E ratio is currently 0.07, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.07
• 2023: 0.02
• 2022: 0.05
• 2021: 0.03

IOL Chemicals & Pharmaceuticals Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The IOL Chemicals & Pharmaceuticals Ltd ROE currently stands at 6.13%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 6.13
• 2023: 8.62
• 2022: 9.60
• 2021: 12.64

Declining ROE indicates pressure on profitability.

IOL Chemicals & Pharmaceuticals Ltd Ratios Analysis Summary

The IOL Chemicals & Pharmaceuticals Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether IOL Chemicals & Pharmaceuticals Ltd stock is undervalued, fairly valued, or overvalued.

Tracking IOL Chemicals & Pharmaceuticals Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.